Literature DB >> 21386874

Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome.

Chirag Patel1, Lisa Cooper-Charles, Dominic J McMullan, Judith M Walker, Val Davison, Jenny Morton.   

Abstract

Gilles de la Tourette syndrome is a complex neuropsychiatric disorder with a strong genetic basis. We identified a male patient with Tourette syndrome-like tics and an apparently balanced de novo translocation [46,XY,t(2;7)(p24.2;q31)]. Further analysis using array comparative genomic hybridisation (CGH) revealed a cryptic deletion at 7q31.1-7q31.2. Breakpoints disrupting this region have been reported in one isolated and one familial case of Tourette syndrome. In our case, IMMP2L, a gene coding for a human homologue of the yeast inner mitochondrial membrane peptidase subunit 2, was disrupted by the breakpoint on 7q31.1, with deletion of exons 1-3 of the gene. The IMMP2L gene has previously been proposed as a candidate gene for Tourette syndrome, and our case provides further evidence of its possible role in the pathogenesis. The deleted region (7q31.1-7q31.2) of 7.2 Mb of genomic DNA also encompasses numerous genes, including FOXP2, associated with verbal dyspraxia, and the CFTR gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21386874      PMCID: PMC3110039          DOI: 10.1038/ejhg.2010.238

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  30 in total

1.  An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries.

Authors:  R D Freeman; D K Fast; L Burd; J Kerbeshian; M M Robertson; P Sandor
Journal:  Dev Med Child Neurol       Date:  2000-07       Impact factor: 5.449

2.  Evidence supporting WNT2 as an autism susceptibility gene.

Authors:  T H Wassink; J Piven; V J Vieland; J Huang; R E Swiderski; J Pietila; T Braun; G Beck; S E Folstein; J L Haines; V C Sheffield
Journal:  Am J Med Genet       Date:  2001-07-08

3.  Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome.

Authors:  E Petek; C Windpassinger; J B Vincent; J Cheung; A P Boright; S W Scherer; P M Kroisel; K Wagner
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

Review 4.  Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects.

Authors:  J V Leonard; A H Schapira
Journal:  Lancet       Date:  2000-01-29       Impact factor: 79.321

5.  Candidate region for Gilles de la Tourette syndrome at 7q31.

Authors:  P M Kroisel; E Petek; W Emberger; C Windpassinger; W Wladika; K Wagner
Journal:  Am J Med Genet       Date:  2001-07-01

6.  The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder.

Authors:  C S Lai; S E Fisher; J A Hurst; E R Levy; S Hodgson; M Fox; S Jeremiah; S Povey; D C Jamison; E D Green; F Vargha-Khadem; A P Monaco
Journal:  Am J Hum Genet       Date:  2000-07-05       Impact factor: 11.025

7.  Identification of the human cortactin-binding protein-2 gene from the autism candidate region at 7q31.

Authors:  J Cheung; E Petek; K Nakabayashi; L C Tsui; J B Vincent; S W Scherer
Journal:  Genomics       Date:  2001-11       Impact factor: 5.736

8.  A forkhead-domain gene is mutated in a severe speech and language disorder.

Authors:  C S Lai; S E Fisher; J A Hurst; F Vargha-Khadem; A P Monaco
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

9.  The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia.

Authors:  Mitsuyuki Matsumoto; Richard E Straub; Stefano Marenco; Kristin K Nicodemus; Shun-Ichiro Matsumoto; Akihiko Fujikawa; Sosuke Miyoshi; Miwako Shobo; Shinji Takahashi; Junko Yarimizu; Masatoshi Yuri; Masashi Hiramoto; Shuji Morita; Hiroyuki Yokota; Takeshi Sasayama; Kazuhiro Terai; Masayasu Yoshino; Akira Miyake; Joseph H Callicott; Michael F Egan; Andreas Meyer-Lindenberg; Lucas Kempf; Robyn Honea; Radha Krishna Vakkalanka; Jun Takasaki; Masazumi Kamohara; Takatoshi Soga; Hideki Hiyama; Hiroyuki Ishii; Ayako Matsuo; Shintaro Nishimura; Nobuya Matsuoka; Masato Kobori; Hitoshi Matsushime; Masao Katoh; Kiyoshi Furuichi; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

10.  High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility.

Authors:  E Maestrini; A T Pagnamenta; J A Lamb; E Bacchelli; N H Sykes; I Sousa; C Toma; G Barnby; H Butler; L Winchester; T S Scerri; F Minopoli; J Reichert; G Cai; J D Buxbaum; O Korvatska; G D Schellenberg; G Dawson; A de Bildt; R B Minderaa; E J Mulder; A P Morris; A J Bailey; A P Monaco
Journal:  Mol Psychiatry       Date:  2009-04-28       Impact factor: 15.992

View more
  25 in total

Review 1.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

2.  Chromosomal rearrangements in Tourette syndrome: implications for identification of candidate susceptibility genes and review of the literature.

Authors:  Birgitte Bertelsen; Nanette Mol Debes; Lena E Hjermind; Liselotte Skov; Karen Brøndum-Nielsen; Zeynep Tümer
Journal:  Neurogenetics       Date:  2013-08-29       Impact factor: 2.660

3.  Suppression of Inner Mitochondrial Membrane Peptidase 2-Like (IMMP2L) Gene Exacerbates Hypoxia-Induced Neural Death Under High Glucose Condition.

Authors:  Yi Ma; Zijing Zhang; Zhirong Chen; Nina Ma; Shihui Sun; Jingwen Zhang; Xinli Ni; Jianzhong Zhang; P Andy Li
Journal:  Neurochem Res       Date:  2017-03-18       Impact factor: 3.996

Review 4.  A Review and Update on Tourette Syndrome: Where Is the Field Headed?

Authors:  Aysegul Gunduz; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

5.  Proteolytic cleavage by the inner membrane peptidase (IMP) complex or Oct1 peptidase controls the localization of the yeast peroxiredoxin Prx1 to distinct mitochondrial compartments.

Authors:  Fernando Gomes; Flávio Romero Palma; Mario H Barros; Eduardo T Tsuchida; Helena G Turano; Thiago G P Alegria; Marilene Demasi; Luis E S Netto
Journal:  J Biol Chem       Date:  2017-08-18       Impact factor: 5.157

6.  Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study.

Authors:  Shanker Swaminathan; Li Shen; Sungeun Kim; Mark Inlow; John D West; Kelley M Faber; Tatiana Foroud; Richard Mayeux; Andrew J Saykin
Journal:  Curr Alzheimer Res       Date:  2012-09       Impact factor: 3.498

7.  Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.

Authors:  Birgitte Bertelsen; Linea Melchior; Lars R Jensen; Camilla Groth; Birte Glenthøj; Renata Rizzo; Nanette Mol Debes; Liselotte Skov; Karen Brøndum-Nielsen; Peristera Paschou; Asli Silahtaroglu; Zeynep Tümer
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

8.  Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia.

Authors: 
Journal:  Biol Psychiatry       Date:  2012-08-09       Impact factor: 13.382

9.  Effect of schizophrenia risk-associated alleles in SREB2 (GPR85) on functional MRI phenotypes in healthy volunteers.

Authors:  Eugenia Radulescu; Fabio Sambataro; Venkata S Mattay; Joseph H Callicott; Richard E Straub; Mitsuyuki Matsumoto; Daniel R Weinberger; Stefano Marenco
Journal:  Neuropsychopharmacology       Date:  2012-09-12       Impact factor: 7.853

Review 10.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.